NCT05500339

Brief Summary

Recent development in information and communication technologies has enabled the disruptive expansion of electronic health (eHealth) and mobile health (mHealth). These developments, along with the introduction in clinical practice of technological innovations, such as telemedicine, telemonitoring, and remote screening, are considered essential elements of "game-changing innovations" in the next 25 years. In fact, the widespread distribution of networked devices, which are estimated to reach 29.3 billion in 2023, offers a promising but challenging opportunity of mHealth use for health information seeking, with an important role in health behavior formation. In 2017, more than 325,000 mobile health applications (apps) were available worldwide, and among them, to the best of our knowledge, there were more apps available to support pregnancy than for any other medical domain. These mobile technologies in support of pregnancy have also increased the possibility for both parents and parents-to-be to self-manage health issues; findings from a recent study conducted in 2019 in Switzerland report that 91% of parents declared using digital media for seeking information about their child's health and development. Moreover, a recent meta-analysis showed that social media and mHealth have the potential to be effective in promoting maternal physical health (e.g., weight management), mental health, and knowledge about pregnancy. However, when considering apps addressing children's first 1000 days of life, from conception through age 24 months, many of them just focus on the prenatal or postnatal stage, failing to consider the continuity between the two phases and their joint impact on maternal and child health. The purpose of this study is to evaluate the mHealth App effectiveness for the support of women during the first 1000 days (from conception through age 24 months) and for improving health prevention behaviors such as vaccination during pregnancy, weight increment during pregnancy, abstinence from smoke and alcohol consumption habits, adherence to child routine vaccination schedule. In addition, the study aims to understand the level of appreciation of this mHealth App as a tool to overcome information and communication gaps between patients and institution.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
360

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 4, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 15, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

November 22, 2022

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

March 18, 2024

Status Verified

March 1, 2024

Enrollment Period

1.5 years

First QC Date

August 4, 2022

Last Update Submit

March 15, 2024

Conditions

Keywords

mHealth applicationfirst 1000 dayshealth prevention

Outcome Measures

Primary Outcomes (1)

  • Between groups differences in the adherence of pregnant women to Tetanus, Diphtheria, Pertussis (TDaP) vaccination

    Number of vaccination in pregnancy carried out in the two groups

    Within the second year of child life

Secondary Outcomes (12)

  • Between groups differences in women knowledge

    Immediately at the end of first trimester of pregnancy

  • Between groups differences in women behaviors

    Immediately at the end of first trimester of pregnancy

  • Between groups differences in women knowledge

    At the end of second trimester of pregnancy

  • Between groups differences in women behaviors

    At the end of second trimester of pregnancy

  • Between groups differences in women knowledge

    Within the second year of child life

  • +7 more secondary outcomes

Study Arms (2)

mHealth App

EXPERIMENTAL

The mHealth App designed for the support of the first 1000 days of life is provided to pregnant women. Specific contents are presented to the user according to the current trimester of pregnancy or the post-partum period following a scheduled routine; all contents are always available for free consultation during the entire period of use. Links to relevant institutional websites are also reported for any further reading. The app has a frequently asked question (FAQ) section, and a calendar function with the possibility to set appointments and reminders. App contents and topics include information about health prevention behaviors such as vaccination during pregnancy, weight increment during pregnancy, abstinence from smoke and alcohol consumption habits, adherence to child routine vaccination schedule.

Other: M-health App

Standard care.

SHAM COMPARATOR

Pregnant women receive standard supportive and educational methods.

Other: Standard care

Interventions

Pregnant women receive the App designed for the support of the first 1000 days of life

mHealth App

Pregnant women receive standard supportive and educational methods.

Standard care.

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant women accessing for the first trimester ultrasound.
  • Age \>= 18 years
  • Good comprehension of Italian language
  • Possession of a smartphone for the App download
  • Willingness to give birth at Institute for Maternal and Child Health Burlo Garofolo, Trieste

You may not qualify if:

  • \- Inability to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute for Maternal and Child Health - IRCCS "Burlo Garofolo"

Trieste, 34137, Italy

RECRUITING

Related Publications (1)

  • Brunelli L, Bussolaro S, Dal Cin M, Ronfani L, Zanchiello S, Cassone A, Verardi G, Dobrina R, Bava M, Stampalija T. CARE 1000: randomized controlled trial for the evaluation of the effectiveness of a mHealth app for supporting the first 1000 days of life. Trials. 2022 Dec 12;23(1):1007. doi: 10.1186/s13063-022-06953-y.

MeSH Terms

Conditions

Health Behavior

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Tamara Stampalija, MD

    Institute for Maternal and Child Health IRCCS Burlo Garofolo

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 4, 2022

First Posted

August 15, 2022

Study Start

November 22, 2022

Primary Completion

May 31, 2024

Study Completion

December 31, 2024

Last Updated

March 18, 2024

Record last verified: 2024-03

Locations